The incidence of fracture among patients with inflammatory dowel disease - A population-based cohort study

被引:353
作者
Bernstein, CN
Blanchard, JF
Leslie, W
Wajda, A
Yu, BN
机构
[1] Univ Manitoba, Gastroenterol Sect, John Buhler Res Ctr, Winnipeg, MB R3E 3P4, Canada
[2] Manitoba Hlth, Winnipeg, MB, Canada
关键词
D O I
10.7326/0003-4819-133-10-200011210-00012
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: The clinical significance of the high prevalence of osteopenia in inflammatory bowel disease is unclear. Objective: To determine whether persons with inflammatory bowel disease have increased incidence of fracture. Design: Population-based matched cohort study. Setting: Manitoba, Canada. Patients: Patients with inflammatory bower disease in the University of Manitoba IBD Database (n = 6027) were matched to 10 randomly selected persons in the general population without inflammatory bowel disease (n = 60 270) by year, age, sex, and postal area of residence. Measurements: The incidence of hospitalization for hip fracture was determined on the basis of hospital discharge abstracts. Outpatient medical billing records and hospital discharge abstracts were used to calculate the incidence of spine, rib, and forearm fractures. Rates were calculated on the basis of person-years of follow-up for 1984 to 1997. Results: Persons with inflammatory bower disease had significantly increased incidence of fractures at the spine (incidence rate ratio [IRR], 1.74 [95% Cl, 1.34 to 2.24]; P < 0.001), hip (IRR, 1.59 [Cl, 1.27 to 2.00]; P < 0.001), wrist/forearm (IRR, 1.33 [Cl, 1.11 to 1.58]; P = 0.001), and rib (IRR, 1.25 [Cl, 1.02 to 1.52]; P = 0.03) and of any of these fractures (IRR, 1.41 [Cl, 1.27 to 1.56]; P < 0.001). Conclusion: The incidence of fracture among persons with inflammatory bowel disease is 40% greater than that in the general population.
引用
收藏
页码:795 / 799
页数:5
相关论文
共 20 条
[1]
Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735
[2]
A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: A pilot study [J].
Bernstein, CN ;
Seeger, LL ;
Anton, PA ;
Artinian, L ;
Geffrey, S ;
Goodman, W ;
Belin, TR ;
Shanahan, F .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (05) :777-786
[3]
BERNSTEIN CN, 1999, TRENDS INFLAMMATORY, P147
[4]
BERNSTEIN CN, 1997, GASTROENTEROL INT, V10, P71
[5]
HORMONE REPLACEMENT THERAPY PREVENTS BONE LOSS IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE [J].
CLEMENTS, D ;
COMPSTON, JE ;
EVANS, WD ;
RHODES, J .
GUT, 1993, 34 (11) :1543-1546
[6]
COMPSTON JE, 1995, ALIMENT PHARM THER, V9, P237
[7]
Accuracy of medical records in hip fracture [J].
Fox, KM ;
Reuland, M ;
Hawkes, WG ;
Hebel, JR ;
Hudson, J ;
Zimmerman, SI ;
Kenzora, J ;
Magaziner, J .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (06) :745-750
[8]
Calcaneal ultrasound bone densitometry in inflammatory bowel disease - A comparison with double X-ray densitometry of the lumbar spine [J].
Fries, W ;
Dinca, M ;
Luisetto, G ;
Peccolo, F ;
Bottega, F ;
Martin, A .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (12) :2339-2344
[9]
Gennari C, 1986, Clin Rheum Dis, V12, P637
[10]
LOW BONE-MINERAL DENSITY IN CROHNS-DISEASE, BUT NOT IN ULCERATIVE-COLITIS, AT DIAGNOSIS [J].
GHOSH, S ;
COWEN, S ;
HANNAN, WJ ;
FERGUSON, A .
GASTROENTEROLOGY, 1994, 107 (04) :1031-1039